ClinicalTrials.gov
ClinicalTrials.gov Menu

Azacitidine With Rituximab, Vincristine, and Cyclophosphamide in Refractory Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00901069
Recruitment Status : Completed
First Posted : May 13, 2009
Last Update Posted : October 17, 2016
Sponsor:
Collaborator:
Celgene
Information provided by (Responsible Party):
Shams Shakil, University of Kentucky

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2012
  Actual Study Completion Date : November 2012